Appetite control and reproduction: Leptin and beyond

Seminars in Reproductive Medicine

Volumn 20, Issue 4, 2002, Pages 389-398

  Small, C J ^a   Stanley, S A ^a   Bloom, S R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Food intake; Ghrelin; Hypothalamus; Leptin; Melanocortins

Indexed keywords

GHRELIN; GONADORELIN; LEPTIN; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR;

AGRP GENE; ANOREXIA NERVOSA; APPETITE; BODY FAT; BODY WEIGHT; CALORIC INTAKE; DOWN REGULATION; ENERGY EXPENDITURE; FEEDING; FERTILITY; GENE; HUMAN; HYPOTHALAMUS; MALNUTRITION; NONHUMAN; NUTRITION; REPRODUCTION; REVIEW;

ANIMALS; APPETITE REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; PEPTIDE HORMONES; PROTEINS; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, CORTICOTROPIN; REPRODUCTION;

EID: 0036868567     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-36712     Document Type: Review

References (118)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432
2. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295
3. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nat Med 1996;2:589-593
4. Hoggard N, Mercer JG, Rayner DV, Moar K, Trayhurn P, Williams LM. Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and in situ hybridization. Biochem Biophys Res Commun 1997;232:383-387
5. Elmquist JK, Bjorbaek C, Ahima RS, Flier JS, Saper CB. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 1998;395:535-547
6. Baskin DG, Breininger JF, Schwartz MW. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes 1999;48:828-833
7. Cheung CC, Clifton DK, Steiner RA. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997;138:4489-4492
8. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci U S A 1996;93:6231-6235
9. Farooqi IS, Keogh JM, Kamath S, et al. Partial leptin deficiency and human adiposity. Nature 2001;414:34-35
10. Farooqi IS, O'Rahilly S. Recent advances in the genetics of severe childhood obesity. Arch Dis Child 2000;83:31-34
11. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999;341:879-884
12. Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 1996;12:318-320
13. Sinha YN, Salocks CB, Vanderlaan WE. Prolactin and growth hormone secretion in chemically induced and genetically obese mice. Endocrinology 1975;97:1386-1393
14. Lord G, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998;394:897-901
15. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-252
16. Ludwig DS, Mountjoy KG, Tatro JB, et al. Melanin-concentrating hormone: A functional melanocortin antagonist in the hypothalamus. Am J Physiol 1998;274:E627-E633
17. Cowley MA, Pronchuk N, Fan W, Dinulescu DM, Colmers WF, Cone RD. Integration of NPY, AGRP and melanocortin signals in the hypothalamic paraventricular nucleus: Evidence of a cellular basis for the adipostat. Neuron 2000;24:155-163
18. Badger TM, Lynch EA, Fox PH. Effects of fasting on leutinizing hormone dynamics in the male rat. J Nutr 1985;115:788-797
19. Yu WH, Kimura M, Walczewska A, Karanth S, McCann SM. Role of leptin in hypothalamic-pituitary function. Proc Natl Acad Sci U S A 1997;94:1023-1028
20. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999;20:68-100
21. Broberger C, Johansen J, Johansson C, Schalling M, Hokfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci U S A 1998;95:15043-15048
22. Kristensen P, Judge ME, Thim L, et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 1998;393:72-76
23. Schwartz MW, Seeley RJ, Woods SC, et al. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997;46:2119-2123
24. Stanley BG, Leibowitz SF. Neuropeptide Y injected in the paraventricular hypothalamus: A powerful stimulant of feeding behavior. Proc Natl Acad Sci U S A 1985;82:3940-3943
25. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity. Peptides 1986;7:1189-1192
26. Lambert PD, Phillips PJ, Wilding JP, Bloom SR, Herbert J. c-fos expression in the paraventricular nucleus of the hypothalamus following intracerebroventricular infusions of neuropeptide Y. Brain Res 1995;670:59-65
27. Bagnol D, Lu XY, Kaelin CB, et al. Anatomy of an endogenous antagonist: Relationship between agouti-related protein and proopiomelanocortin in brain. J Neurosci 1999;19:RC26
28. Stanley BG, Anderson KC, Grayson MH, Leibowitz SF. Repeated hypothalamic stimulation with neuropeptide Y increases daily carbohydrate and fat intake and body weight gain in female rats. Physiol Behav 1989;46:173-177
29. Sanacora G, Kershaw M, Finkelstein JA, White JD. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 1990;127:730-737
30. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature 2001;409:194-198
31. Schwartz MW, Baskin DG, Bukowski TR, et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996;45:531-535
32. Shibasaki T, Oda T, Imaki T, Ling N, Demura H. Injection of anti-neuropeptide Y gamma-globulin into the hypothalamic paraventricular nucleus decreases food intake in rats. Brain Res 1993;601:313-316
33. Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996;381:415-421
34. Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996;274:1704-1707
35. Naveilhan P, Hassani H, Canals JM, et al. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nat Med 1999;5:1188-1193
36. Billington CJ, Briggs JE, Grace M, Levine AS. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol 1991;260:R321-R327
37. Fekete C, Kelly J, Mihaly E, et al. Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis. Endocrinology 2001;142:2606-2613
38. Li C, Chen P, Smith MS. Morphological evidence for direct interaction between arcuate nucleus neuropeptide Y (NPY) neurons and gonadotropin-releasing hormone neurons and the possible involvement of NPY Y1 receptors. Endocrinology 1999;140:5382-5390
39. Sahu A, Phelps CP, White JD, Crowley WR, Kalra SP, Kalra PS. Steroidal regulation of hypothalamic neuropeptide Y release and gene expression. Endocrinology 1992;130:3331-3336
40. Crowley WR, Kalra SP. Neuropeptide Y stimulates the release of luteinizing hormone-releasing hormone from medial basal hypothalamus in vitro: Modulation by ovarian hormones. Neuroendocrinology 1987;46:97-103
41. Kalra SP, Kalra PS, Sahu A, Crowley WR. Gonadal steroids and neurosecretion: Facilitatory influence on LHRH and neuropeptide Y. J Steroid Biochem 1987;27:677-682
42. Kaynard AH, Pau KY, Hess DL, Spies HG. Third-ventricular infusion of neuropeptide Y suppresses luteinizing hormone secretion in ovariectomized rhesus macaques. Endocrinology 1990;127:2437-2444
43. Kalra SP, Crowley WR. Neuropeptide Y: A novel neuroendocrine peptide in the control of pituitary hormone secretion, and its relation to luteinizing hormone. Front Neuroendocrinol 1992;13:1-46
44. Kalra PS, Bonavera JJ, Kalra SP. Central administration of antisense oligodeoxynucleotides to neuropeptide Y (NPY) mRNA reveals the critical role of newly synthesized NPY in regulation of LHRH release. Regul Pept 1995;59:215-220
45. Kalra PS, Dube MG, Kalra SP. Effects of centrally administered antisense oligodeoxynucleotides on feeding behavior and hormone secretion. Methods Enzymol 2000;314:184-200
46. McDonald JK, Lumpkin MD, Samson WK, McCann SM. Neuropeptide Y affects secretion of luteinizing hormone and growth hormone in ovariectomized rats. Proc Natl Acad Sci U S A 1985;82:561-564
47. Schulz R, Wilhelm A, Pirke KM, Gramsch C, Herz A. Beta-endorphin and dynorphin control serum luteinizing hormone level in immature female rats. Nature 1981;294:757-759
48. Kalra SP, Allen LG, Sahu A, Kalra PS, Crowley WR. Gonadal steroids and neuropeptide Y-opioid-LHRH axis: Interactions and diversities. J Steroid Biochem 1988;30:185-193
49. Simonian SX, Spratt DP, Herbison AE. Identification and characterization of estrogen receptor alpha-containing neurons projecting to the vicinity of the gonadotropin-releasing hormone perikarya in the rostral preoptic area of the rat. J Comp Neurol 1999;411:346-358
50. Faletti AG, Mastronardi CA, Lomniczi A, et al. Beta-Endorphin blocks luteinizing hormone-releasing hormone release by inhibiting the nitricoxidergic pathway controlling its release. Proc Natl Acad Sci U S A 1999;96:1722-1726
51. Walsh JP, Clarke IJ. Effects of central administration of highly selective opioid mu-, delta- and kappa-receptor agonists on plasma luteinizing hormone (LH), prolactin, and the estrogen-induced LH surge in ovariectomized ewes. Endocrinology 1996;137:3640-3648
52. Scimonelli T, Celis ME. Modifications in alpha-MSH concentrations in different hypothalamic areas during the estrous cycle in the rat. Acta Physiol Pharmacol Latinoam 1986;36:431-437
53. Bohler HC Jr, Tracer H, Merriam GR, Petersen SL. Changes in proopiomelanocortin messenger ribonucleic acid levels in the rostral periarcuate region of the female rat during the estrous cycle. Endocrinology 1991;128:1265-1269
54. Gosnell BA, Levine AS, Morley JE. The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors. Life Sci 1986;38:1081-1088
55. McLean S, Hoebel BG. Feeding induced by opiates injected into the paraventricular hypothalamus. Peptides 1983;4:287-292
56. Simone DA, Bodnar RJ, Goldman EJ, Pasternak GW. Involvement of opioid receptor subtypes in rat feeding behavior. Life Sci 1985;36:829-833
57. Arjune D, Bodnar RJ. Suppression of nocturnal, palatable and glucoprivic intake in rats by the kappa opioid antagonist, nor-binaltorphamine. Brain Res 1990;534:313-316
58. Horvath TL, Naftolin F, Leranth C. Beta-endorphin innervation of dopamine neurons in the rat hypothalamus: A light and electron microscopic double immunostaining study. Endocrinology 1992;131:1547-1555
59. Kalra PS, Norlin M, Kalra SP. Neuropeptide Y stimulates beta-endorphin release in the basal hypothalamus: Role of gonadal steroids. Brain Res 1995;705:353-356
60. Garcia MM, Brown HE, Harlan RE. Alterations in immediate-early gene proteins in the rat forebrain induced by acute morphine injection. Brain Res 1995;692:23-40
61. Xu B, Sahu A, Kalra PS, Crowley WR, Kalra SP. Disinhibition from opioid influence augments hypothalamic neuropeptide Y (NPY) gene expression and pituitary luteinizing hormone release: Effects of NPY messenger ribonucleic acid antisense oligodeoxynucleotides. Endocrinology 1996;137:78-84
62. Kandeel FR, Swerdloff RS. The interaction between betaendorphin and gonadal steroids in regulation of luteinizing hormone (LH) secretion and sex steroid regulation of LH and proopiomelanocortin peptide secretion by individual pituitary cells. Endocrinology 1997;138:649-656
63. Leranth C, Sakamoto H, MacLusky NJ, Shanabrough M, Naftolin F. Application of avidin-ferritin and peroxidase as contrasting electron- dense markers for simultaneous electron microscopic immunocytochemical labelling of glutamic acid decarboxylase and tyrosine hydroxylase in the rat arcuate nucleus. Histochemistry 1985;82:165-168
64. Jung H, Shannon EM, Fritschy JM, Ojeda SR. Several GABAA receptor subunits are expressed in LHRH neurons of juvenile female rats. Brain Res 1998;780:218-229
65. McCarthy MM, Kaufman LC, Brooks PJ, Pfaff DW, Schwartz-Giblin S. Estrogen modulation of mRNA levels for the two forms of glutamic acid decarboxylase (GAD) in female rat brain. J Comp Neurol 1995;360:685-697
66. Mitsushima D, Hei DL, Terasawa E. Gamma-aminobutyric acid is an inhibitory neurotransmitter restricting the release of luteinizing hormone-releasing hormone before the onset of puberty. Proc Natl Acad Sci U S A 1994;91:395-399
67. Gore AC, Roberts JL. Regulation of gonadotropin-releasing hormone gene expression in vivo and in vitro. Front Neuroendocrinol 1997;18:209-245
68. Mitsushima D, Marzban F, Luchansky LL, et al. Role of glutamic acid decarboxylase in the prepubertal inhibition of the luteinizing hormone releasing hormone release in female rhesus monkeys. J Neurosci 1996;16:2563-2573
69. Turton MD, O'Shea D, Gunn I, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996;379:69-72
70. Tang-Christensen M, Larsen PJ, Thulesen J, Romer J, Vrang N. The proglucagon-derived peptide; glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat Med 2000;6:802-807
71. Dakin CL, Gunn I, Small CJ, et al. Oxyntomodulin inhibits food intake in the rat. Endocrinology 2001;142:4244-4250
72. Scrocchi LA, Brown TJ, MacLusky NJ, et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 1996;2:1254-1258
73. Beak SA, Heath MM, Small CJ, et al. Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line. J Clin Invest 1998;101:1334-1341
74. MacLusky NJ, Cook S, Scrocchi L, et al. Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling. Endocrinology 2000;141:752-762
75. Boston BA, Blaydon KM, Varnerin J, Cone RD. Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 1997;278:1641-1644
76. Barsh G. From Agouti to Pomc: 100 Years of fat blonde mice. Nat Med 1999;5:984-985
77. Cone RD. The central melanocortin system and its role in energy homeostasis. Ann Endocrinol (Paris) 1999;60:3-9
78. Rossi M, Kim MS, Morgan DG, et al. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 1998;139:4428-4431
79. Quillan JM, Sadee W, Wei ET, Jimenez C, Ji L, Chang JK. A synthetic human Agouti-related protein-(83-132)-NH2 fragment is a potent inhibitor of melanocortin receptor function. FEBS Lett 1998;428:59-62
80. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997;385:165-168
81. Small CJ, Kim MS, Stanley SA, et al. Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. Diabetes 2001;50:248-254
82. Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-141
83. Graham M, Shutter JR, Sarmiento U, Sarosi I, Stark KL. Overexpression of Agrt leads to obesity in transgenic mice. Nat Genet 1997;17:273-274
84. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin [see comments]. Nat Med 1999;5:1066-1070
85. Ste-Marie L, Miura GI, Marsh DJ, Yagaloff K, Palmiter RD. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Nad Acad Sci U S A 2000;97:12339-12344
86. Butler AA, Kesterson RA, Khong K, et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000;141:3518-3521
87. Kim MS, Small CJ, Stanley SA, et al. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest 2000;105:1005-1011
88. Forbes S, Bui S, Robinson BR, Hochgeschwender U, Brennan MB. Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. Proc Natl Acad Sci U S A 2001;98:4233-4237
89. Blake NG, Eckland DJ, Foster OJ, Lightman SL. Inhibition of hypothalamic thyrotropin-releasing hormone messenger ribonucleic acid during food deprivation. Endocrinology 1991;129:2714-2718
90. Jackson RS, O'Rahilly S, Brain C, Nussey SS. Proopiomelanocortin products and human early-onset obesity. J Clin Endocrinol Metab 1999;84:819-820
91. Yeo GS, Farooqi IS, Challis BG, Jackson IJ, O'Rahilly S. The role of melanocortin signalling in the control of body weight: Evidence from human and murine genetic models. Q J Med 2000;93:7-14
92. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000;106:253-262
93. Vink T, Hinney A, van Elburg AA, et al. Association between an agouti-related protein gene polymorphism and anorexia nervosa. Mol Psychiatry 2001;6:325-328
94. Fehm HL, Smolnik R, Kern W, McGregor GP, Bickel U, Born J. The melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4-10) decreases body fat in humans. J Clin Endocrinol Metab 2001;86:1144-1148
95. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994;8:1298-1308
96. Williams G, Cardoso HM, Lee YC, et al. Hypothalamic regulatory peptides in obese and lean Zucker rats. Clin Sci (Lond) 1991;80:419-426
97. Mezey E, Kiss JZ, Mueller GP, Eskay R, O'Donohue HL, Palkovits M. Distribution of the pro-opiomelanocortin derived peptides, adrenocorticotrope hormone, alpha-melanocyte-stimulating hormone and beta-endorphin (ACTH, alpha-MSH, beta-END) in the rat hypothalamus. Brain Res 1985;328:341-347
98. Stanley SA, Small CJ, Kim MS, et al. Agouti related peptide (Agrp) stimulates the hypothalamo pituitary gonadal axis in vivo & in vitro in male rats. Endocrinology 1999;140:5459-5462
99. Watanobe H, Suda T, Wikberg JE, Schioth HB. Evidence that physiological levels of circulating leptin exert a stimulatory effect on luteinizing hormone and prolactin surges in rats. Biochem Biophys Res Commun 1999;263:162-165
100. Limone P, Calvelli P, Altare F, Ajmone-Catt P, Lima T, Molinatti GM. Evidence for an interaction between alpha-MSH and opioids in the regulation of gonadotropin secretion in man. J Endocrinol Invest 1997;20:207-210
101. Granholm NH, Jeppesen KW, Japs RA. Progressive infertility in female lethal yellow mice (Ay/a; strain C57BL/6J). J Reprod Fertil 1986;76:279-287
102. Lambert PD, Couceyro PR, McGirr KM, Dall Vechia SE, Smith Y, Kuhar MJ. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 1998;29:293-298
103. Stanley SA, Small CJ, Murphy KG, et al. Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Res 2001;893:186-194
104. Abbott CR, Rossi M, Wren AM, et al. Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology 2001;142:3457-3463
105. Koylu EO, Couceyro PR, Lambert PD, Ling NC, DeSouza EB, Kuhar MJ. Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland. J Neuroendocrinol 1997;9:823-833
106. Kojima M, Hosoda H, Matsuo H, Kangawa K. Ghrelin: Discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001;12:118-122
107. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000;407:908-913
108. Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000;141:4325-4328
109. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660
110. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992
111. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001;50:1714-1719
112. Wren AM, Small CJ, Abbott CR, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001;50:2540-2547
113. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001;50:707-709
114. Ravussin E, Tschop M, Morales S, Bouchard C, Heiman ML. Plasma ghrelin concentration and energy balance: Overfeeding and negative energy balance studies in twins. J Clin Endocrinol Metab 2001;86:4547-4551
115. Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001;86:4753-4758
116. Kaji H, Tai S, Okimura Y, et al. Cloning and characterization of the 5′-flanking region of the human growth hormone secretagogue receptor gene. J Biol Chem 1998;273:33885-33888
117. Asakawa A, Inui A, Kaga T, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001;120:337-345
118. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 2000;141:4797-4800